Tabled 1
PPI, proton pumps inhibitor.
In the updated analysis newly initiated therapy separated from ongoing therapy the associations between newly initiated treatment with lansoprazole as well as ongoing treatment with omeprazole and “any proton pump inhibitor” were now statistically significant.Tabled 1
PPI, proton pumps inhibitor. *Newly initiated rabeprazole could not be analyzed since no case nor control had been newly initiated.
The conclusion as published in the article was “With the exception of lansoprazole, this study suggests an association between any newly initiated PPI-treatment and hospitalization due to hyponatremia. Ongoing PPI use was not associated with an increased risk.”
In the light of the revised analysis, we now conclude:
“This study suggests an association between any newly initiated PPI-treatment and hospitalization due to hyponatremia. The excess risk largely disappeared during ongoing treatment.”
The authors would like to apologise for any inconvenience caused.
ReferenceFalhammar H Lindh JD Calissendorff J Skov J Nathanson D Mannheimer B.Associations of proton pump inhibitors and hospitalization due to hyponatremia: A population-based case-control study.
Eur J Intern Med. 59: 65-69Article InfoPublication HistoryPublished online: June 23, 2021
Accepted: May 15, 2021
Publication stageIn Press Corrected ProofIdentificationDOI: https://doi.org/10.1016/j.ejim.2021.05.041
Copyright© 2018 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
ScienceDirectAccess this article on ScienceDirect Linked ArticleRelated Articles
Comments (0)